Phase I BP Interferon (IFN) Beta-001

Clinical trial NCT02515695 · COMPLETED

Trial details

NCT number: NCT02515695
Sponsor: Centre Hospitalier Universitaire Vaudois
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2005-05-01
Primary completion: 2005-07-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.